219 related articles for article (PubMed ID: 19489032)
1. Is the non-respect of ethical principles by health professionals during first-trimester sonographic Down syndrome screening damaging to patient autonomy?
Favre R; Guige V; Weingertner AS; Vayssière C; Kohler M; Nisand I; Hervé C; Moutel G
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):25-32. PubMed ID: 19489032
[TBL] [Abstract][Full Text] [Related]
2. What about informed consent in first-trimester ultrasound screening for Down syndrome?
Favre R; Moutel G; Duchange N; Vayssière C; Kohler M; Bouffet N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Nisand I
Fetal Diagn Ther; 2008; 23(3):173-84. PubMed ID: 18417975
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of patients' knowledge of first-trimester combined Down syndrome screening at the time of their first trimester ultrasonographic evaluation: Results of a prospective study about 201 women].
de Villardi de Montlaur D; Desseauve D; Marechaud M; Pierre F
J Gynecol Obstet Biol Reprod (Paris); 2016 Jan; 45(1):62-70. PubMed ID: 25869443
[TBL] [Abstract][Full Text] [Related]
4. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
5. Midwives' attitudes to and knowledge about a newly introduced foetal screening method.
Ekelin M; Crang-Svalenius E
Scand J Caring Sci; 2004 Sep; 18(3):287-93. PubMed ID: 15355523
[TBL] [Abstract][Full Text] [Related]
6. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
[TBL] [Abstract][Full Text] [Related]
7. [First trimester screening for Down syndrome in a French perinatal healthcare network].
Letourneau A; Benachi A; Egoroff C
J Gynecol Obstet Biol Reprod (Paris); 2013 Nov; 42(7):647-54. PubMed ID: 23790962
[TBL] [Abstract][Full Text] [Related]
8. [Down syndrome screening in France: the worst consensus].
Rozenberg P; Bussières L; Senat MV
J Gynecol Obstet Biol Reprod (Paris); 2007 Apr; 36(2):95-103. PubMed ID: 17289296
[TBL] [Abstract][Full Text] [Related]
9. First-trimester Down syndrome screening: pregnant women's knowledge.
Dahl K; Hvidman L; Jørgensen FS; Henriques C; Olesen F; Kjaergaard H; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
[TBL] [Abstract][Full Text] [Related]
10. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
Jaques AM; Sheffield LJ; Halliday JL
Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
[TBL] [Abstract][Full Text] [Related]
11. Informed decision-making about the fetal anomaly scan: what knowledge is relevant?
Schoonen HM; Essink-Bot ML; Van Agt HM; Wildschut HI; Steegers EA; De Koning HJ
Ultrasound Obstet Gynecol; 2011 Jun; 37(6):649-57. PubMed ID: 21154787
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21.
Chervenak FA; McCullough LB; Chasen ST
Semin Perinatol; 2005 Aug; 29(4):277-9. PubMed ID: 16104682
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
14. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the impact of screen-positive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: a pilot study.
Weinans MJ; Kooij L; Müller MA; Bilardo KM; Van Lith JM; Tymstra T
Prenat Diagn; 2004 May; 24(5):347-51. PubMed ID: 15164407
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of prenatal screening and psychological management of test decisions.
Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
[TBL] [Abstract][Full Text] [Related]
18. Attitude, knowledge and informed choice towards prenatal screening for Down Syndrome: a cross-sectional study.
Pop-Tudose ME; Popescu-Spineni D; Armean P; Pop IV
BMC Pregnancy Childbirth; 2018 Nov; 18(1):439. PubMed ID: 30419853
[TBL] [Abstract][Full Text] [Related]
19. [Down syndrome screening by ultrasound].
Rozenberg P
Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
[TBL] [Abstract][Full Text] [Related]
20. Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results.
Chueh HY; Cheng PJ; Shaw SW; Lin CT; Hsu JJ; Hsieh TT
Acta Obstet Gynecol Scand; 2007; 86(12):1437-41. PubMed ID: 17851819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
